FibroGen Correlations
| FGENDelisted Stock | USD 9.22 0.29 3.05% |
The current 90-days correlation between FibroGen and Kezar Life Sciences is -0.17 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FibroGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FibroGen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
FibroGen Correlation With Market
Excellent diversification
The correlation between FibroGen and DJI is -0.7 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and DJI in the same portfolio, assuming nothing else is changed.
FibroGen |
Moving together with FibroGen Stock
Moving against FibroGen Stock
| 0.71 | MRK | Merck Company Earnings Call This Week | PairCorr |
| 0.66 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.65 | WF | Woori Financial Group | PairCorr |
| 0.64 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.62 | MCD | McDonalds Sell-off Trend | PairCorr |
| 0.61 | CAT | Caterpillar | PairCorr |
| 0.59 | AXP | American Express | PairCorr |
| 0.55 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
| 0.53 | BCH | Banco De Chile Earnings Call This Week | PairCorr |
| 0.45 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.38 | BAC-PL | Bank of America | PairCorr |
| 0.35 | KB | KB Financial Group | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between FibroGen Stock performing well and FibroGen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze FibroGen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KZR | 0.72 | (0.01) | (0.05) | (0.01) | 1.04 | 1.46 | 7.79 | |||
| TPST | 4.69 | (1.55) | 0.00 | (2.09) | 0.00 | 7.92 | 57.69 | |||
| ALGS | 4.54 | (0.11) | 0.00 | 0.52 | 0.00 | 10.16 | 28.43 | |||
| OKUR | 4.09 | 0.02 | 0.00 | 0.13 | 4.36 | 9.79 | 23.27 | |||
| MRSN | 7.16 | 3.64 | 0.83 | (1.26) | 2.27 | 7.25 | 210.61 | |||
| XFOR | 3.51 | 0.35 | 0.08 | 1.43 | 3.78 | 9.63 | 36.44 | |||
| PDSB | 4.02 | (0.06) | 0.00 | 0.02 | 4.67 | 8.60 | 27.78 | |||
| CELU | 3.58 | (0.67) | 0.00 | (0.67) | 0.00 | 9.01 | 26.97 | |||
| XLO | 2.15 | (0.39) | 0.00 | (0.51) | 0.00 | 4.69 | 15.41 | |||
| ATNM | 3.07 | (0.42) | 0.00 | (0.80) | 0.00 | 5.84 | 20.75 |
Delisting Warning - FGEN
FibroGen was delisted
| The entity FibroGen with a symbol FGEN was delisted from NASDAQ Exchange. Please try Kyntra Bio with a symbol KYNB from now on. Check all delisted instruments accross multiple markets. |
FibroGen Corporate Management
| Kirk MBA | Chief Officer | Profile | |
| Rahul Kaushik | Technical Development | Profile | |
| Mr JD | Chief Officer | Profile | |
| Enrique Conterno | CEO Director | Profile | |
| Barry Berkowitz | Founder | Profile | |
| Christine Chung | Senior Operations | Profile |
Still Interested in FibroGen?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.